November 2, 2011

Transplantation Center testing confirms that Prodo Islet Media out performs CRML based media by a considerable margin. Worldwide testing is underway at additional centers.

June 1, 2011

Prodo Labs officially launched their cGMP Islet Culture Media (Prodo Islet Media-PIM) at the International Pancreas and Islet Transplant Association meeting in Prague. Please visit our cGMP Products section for more information.

February 14, 2011

Prodo Labs has now shipped over 16 million islets to both the corporate and academic communities, with purity averaging 85-90% and viability averaging 95%.

November 5, 2010

Prodo Labs announces being the recipient of two new grants from the Qualifying Therapeutic Discovery Grant (QTDG) funds from a combined NIH/IRS program to provide stimulus funds to small businesses working to develop new health care products. The first grant is for...

October 1, 2010

Prodo Labs announces its ability to begin supplying human islets from Type 2 Diabetes research pancreas donors directly to corporate and academic investigators. There is a need for supplying human islets processed from Type 2 Diabetes pancreases. These are obtained...

July 1, 2010

Prodo Labs publishes a new article in Transplantation Proceedings regarding its success in processing large quantities of human islets from research pancreas donors with long cold ischemia times. Prodo Labs has published its most recent results of processing and...

April 21, 2010

Prodo Labs and the Scharp-Lacy Research Institute collaborate to increase the numbers of high quality human islets for distribution through a new contract with the National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) of the National Institutes of...

October 15, 2009

Prodo Labs announces cut back in activities due to reduced islet orders from the economic turndown. With slow down in the economy, major corporate pharmaceutical companies are changing their priorities in their research operations and reducing the number of human...